REGENERON PHARMACEUTICALS, INC. Diversified Active

CIK: 0000872589 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 2, 2025

Total Value ($000): $1,234,240 (100.0% shares, 0.0% debt)

Holdings (6)

ALNY Alnylam Pharmaceuticals, Inc. 97.2%

Value ($000) $1,200,089 Shares 4,444,445 Est. Cost $262.99 Unrealized -2.3%

NTLA Intellia Therapeutics, Inc. 2.1%

Value ($000) $26,328 Shares 3,702,995 Est. Cost $15.61 Unrealized -35.3%

— 2seventy Bio, Inc. 0.5%

Value ($000) $6,199 Shares 1,254,827 Est. Cost $2.94 Unrealized —

— Adverum Biotechnologies, Inc. 0.1%

Value ($000) $791 Shares 180,909 Est. Cost $4.67 Unrealized —

— Adicet Bio, Inc. 0.1%

Value ($000) $731 Shares 968,183 Est. Cost $0.96 Unrealized —

— Bluebird Bio, Inc. 0.0%

Value ($000) $102 Shares 21,000 Est. Cost $8.34 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALNY	Alnylam Pharmaceuticals, Inc.	4,444,445	$1,200,089	97.2%	$262.99	-2.3%	Common Stock	02043Q107
NTLA	Intellia Therapeutics, Inc.	3,702,995	$26,328	2.1%	$15.61	-35.3%	Common Stock	45826J105
—	2seventy Bio, Inc.	1,254,827	$6,199	0.5%	$2.94	—	Common Stock	901384107
—	Adverum Biotechnologies, Inc.	180,909	$791	0.1%	$4.67	—	Common Stock	00773U207
—	Adicet Bio, Inc.	968,183	$731	0.1%	$0.96	—	Common Stock	007002108
—	Bluebird Bio, Inc.	21,000	$102	0.0%	$8.34	—	Common Stock	09609G209